Cell and Bioscience

Scope & Guideline

Connecting Researchers to Transformative Discoveries

Introduction

Welcome to your portal for understanding Cell and Bioscience, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationCELL BIOSCI / Cell Biosci.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Cell and Bioscience' aims to advance knowledge in the fields of cellular and bioscience research through the dissemination of high-quality research articles that span a wide range of topics. Its core focus includes understanding cellular mechanisms, interactions, and the underlying biological processes that affect health and disease.
  1. Cellular Mechanisms and Signaling Pathways:
    Research articles often explore intricate signaling pathways and cellular mechanisms, including the role of various proteins, RNA modifications, and metabolic processes in health and disease.
  2. Stem Cell Biology and Regenerative Medicine:
    The journal frequently publishes studies on stem cell biology, differentiation, and their therapeutic applications in regenerative medicine and tissue engineering.
  3. Cancer Biology and Therapeutics:
    A significant portion of the research focuses on cancer biology, examining tumor biology, metastasis, and exploring novel therapeutic strategies and biomarkers.
  4. Neuroscience and Neurodegenerative Diseases:
    The journal addresses various aspects of neuroscience, including neural development, neuroinflammation, and neurodegenerative diseases, contributing to a better understanding of brain-related disorders.
  5. Microbiology and Infectious Diseases:
    Research on host-pathogen interactions, immune responses, and the development of therapeutic interventions against infectious diseases is a prominent theme.
  6. Metabolism and Disease:
    Studies related to metabolic disorders, their cellular mechanisms, and potential therapeutic interventions are also key areas of focus.
The journal is currently witnessing the emergence of several trending themes that reflect the latest advancements in cellular and bioscience research. These themes indicate a shift towards interdisciplinary approaches and innovative methodologies.
  1. RNA Modifications and Epitranscriptomics:
    There is a growing emphasis on the role of RNA modifications, particularly m6A and other epitranscriptomic changes, in regulating gene expression and their implications in various diseases, including cancer and neurodegenerative disorders.
  2. Microbiome and Host Interactions:
    Research exploring the interplay between the microbiome and host health is on the rise, particularly its influence on metabolic diseases, immune responses, and cancer progression.
  3. Organoid Models for Disease Modeling:
    The use of organoid technology is increasingly prominent, providing innovative platforms for studying disease mechanisms and testing therapeutic interventions in a more physiologically relevant context.
  4. Immunotherapy and Cancer Immunology:
    Publications focusing on the mechanisms of immunotherapy, including the role of immune checkpoints and the tumor microenvironment, are trending as researchers seek to enhance treatment efficacy.
  5. Metabolic Reprogramming in Cancer:
    Emerging studies are increasingly focusing on the metabolic pathways in cancer cells, exploring how metabolic reprogramming contributes to tumorigenesis and resistance to therapies.
  6. Gene Editing Technologies and Applications:
    The application of CRISPR/Cas9 and other gene editing technologies is gaining traction, with research exploring their potential in therapeutic contexts and the ethical implications surrounding their use.

Declining or Waning

While 'Cell and Bioscience' continues to evolve, certain themes appear to be declining in frequency or prominence. This may reflect shifts in research priorities or advancements in related fields.
  1. Basic Mechanisms of Epithelial-Mesenchymal Transition (EMT):
    Although EMT has been a significant area of study in cancer biology, the frequency of publications focusing solely on the mechanistic aspects of EMT appears to be decreasing, possibly due to a shift towards more integrative approaches that encompass broader cellular interactions.
  2. Traditional Pharmacological Approaches:
    There is a noticeable reduction in studies highlighting traditional pharmacological interventions, as the journal's focus is increasingly leaning towards innovative therapies, including gene editing and personalized medicine.
  3. In Vitro Models of Disease:
    The use of conventional in vitro models is becoming less prominent, as researchers are moving towards more complex and physiologically relevant models such as organoids and 3D cultures.
  4. Single-Cell Analysis Techniques:
    While single-cell technologies have gained significant attention, the specific focus on traditional single-cell sequencing methods is waning, with a greater emphasis now on integrating these techniques with spatial transcriptomics.

Similar Journals

Cell Communication and Signaling

Unleashing Insights into Cell Communication Dynamics
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

BIOCELL

Unveiling the Secrets of Cellular Innovation
Publisher: TECH SCIENCE PRESSISSN: 0327-9545Frequency: 12 issues/year

BIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.

BMC Molecular and Cell Biology

Connecting researchers through groundbreaking discoveries.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.

NEUROCHEMISTRY INTERNATIONAL

Fueling Scientific Collaboration in Neurobiological Innovations
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0197-0186Frequency: 10 issues/year

NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

BIOSCIENCE REPORTS

Empowering the Scientific Community Through Knowledge
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

JOURNAL OF CELLULAR BIOCHEMISTRY

Connecting Researchers Through Cutting-Edge Biochemical Studies
Publisher: WILEYISSN: 0730-2312Frequency: 12 issues/year

Journal of Cellular Biochemistry is a premier academic journal dedicated to advancing the field of biochemistry and cellular biology. Published by Wiley, this influential journal has a significant impact factor that underscores its relevance and authority within the scientific community. With its ISSN 0730-2312 and E-ISSN 1097-4644, the journal has been on the frontier of research since its inception in 1982, and is expected to continue publishing cutting-edge studies through 2024. As evidenced by its ranking in the 2023 Scopus Quartiles, it holds a rank of Q2 in Biochemistry and Q3 in both Cell and Molecular Biology, placing it among the top tiers of scientific journals in these disciplines. The Journal of Cellular Biochemistry serves as a vital resource for researchers, professionals, and students alike, providing a platform for the dissemination of innovative ideas and findings that shape our understanding of cellular processes and biochemical pathways. Though it does not currently offer Open Access options, its robust peer-review process ensures that each publication meets the highest academic standards, thus solidifying its esteemed position in the landscape of biochemical research.

Frontiers in Bioscience-Landmark

Advancing the Frontiers of Biological Discovery
Publisher: IMR PRESSISSN: 2768-6701Frequency: 12 issues/year

Frontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.

FASEB BioAdvances

Elevating Understanding of Biological Processes Globally
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

CELL PROLIFERATION

Advancing the Frontiers of Cellular Research
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

LIFE SCIENCES

Connecting researchers to groundbreaking discoveries in life sciences.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0024-3205Frequency: 24 issues/year

LIFE SCIENCES, published by PERGAMON-ELSEVIER SCIENCE LTD, is an esteemed international journal that has been advancing the field since its inception in 1962. With an ISSN of 0024-3205 and an E-ISSN of 1879-0631, it serves as a critical forum for researchers, professionals, and students within the realms of biochemistry, genetics, molecular biology, medicine, and pharmacology. Currently ranked in the Q1 category across multiple disciplines, including a remarkable 2nd rank in General Pharmacology, Toxicology, and Pharmaceutics, the journal maintains a prestigious position in academic circles, evidenced by its high impact factor and significant percentile ranks. While LIFE SCIENCES is not an open-access journal, it remains dedicated to publishing high-quality, peer-reviewed research that pushes the boundaries of knowledge and fosters innovation. With converged research interests leading into 2024, LIFE SCIENCES continues to be a pivotal resource for the dissemination of influential findings, making it an indispensable tool for those engaged in the life sciences.